|
|
|
Volumn 54, Issue 4, 2015, Pages 317-321
|
|
1,25(OH)2-Vitamin-D3 attenuates Th17-related cytokines expression in peripheral blood mononuclear cells in patients with early-diagnosed rheumatoid arthritis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
COLECALCIFEROL;
CYTOKINE;
DIHYDROXY-VITAMIN D3;
INTERLEUKIN 17;
INTERLEUKIN 6;
INTERLEUKIN DERIVATIVE;
INTERLEUKIN-22;
MESSENGER RNA;
METHOTREXATE;
TUMOR NECROSIS FACTOR ALPHA;
VITAMIN;
VITAMIN D;
ANALOGS AND DERIVATIVES;
ARTHRITIS, RHEUMATOID;
CASE CONTROL STUDY;
DOSE RESPONSE;
DRUG EFFECTS;
EARLY DIAGNOSIS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GENETICS;
HUMAN;
IMMUNOLOGY;
MALE;
METABOLISM;
MIDDLE AGED;
MONONUCLEAR CELL;
TH17 CELL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CASE-CONTROL STUDIES;
CHOLECALCIFEROL;
CYTOKINES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
EARLY DIAGNOSIS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMANS;
INTERLEUKIN-17;
INTERLEUKIN-6;
INTERLEUKINS;
LEUKOCYTES, MONONUCLEAR;
MALE;
METHOTREXATE;
MIDDLE AGED;
RNA, MESSENGER;
TH17 CELLS;
TUMOR NECROSIS FACTOR-ALPHA;
VITAMIN D;
VITAMINS;
|
|
EID: 84944672231
PISSN: 05781426
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
